|
⚲
|
| Keyboard |
| Shannon John Patrick Jr
✚
|
|
|---|---|
| CIK # | 0001553595 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001553595] | |
| 4 | [0001553595] | |
| 5 | [0001553595] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Xeris Biopharma Holdings Inc | |
| Shannon John Patrick Jr | |
| Xeris Pharmaceuticals Inc | |
| Durata Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2026-01-31 | Tax withheld | 118,134 | $7.36 | 869,466 |
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2026-01-31 | Tax withheld | 111,621 | $7.36 | 821,531 |
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2026-01-31 | Tax withheld | 110,750 | $7.36 | 815,120 |
|
Xeris Biopharma Holdings Inc XERS
Stock Option (Right to Buy) · derivative
|
2026-01-30 | Grant | 639,639 | $0.00 | |
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2026-01-30 | Grant | 478,436 | $0.00 | |
|
Xeris Biopharma Holdings Inc XERS
Stock Option (Right to Buy) · derivative
|
2026-01-05 | Option exercise | 25,136 | $0.00 | |
|
Xeris Biopharma Holdings Inc XERS
Stock Option (Right to Buy) · derivative
|
2026-01-05 | Option exercise | 64,265 | $0.00 | |
|
Xeris Biopharma Holdings Inc XERS
Stock Option (Right to Buy) · derivative
|
2026-01-05 | Option exercise | 2,900 | $0.00 | |
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2026-01-05 | Sell | 24,907 | $7.08 | 176,342 |
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2026-01-05 | Option exercise | 2,900 | $3.94 | 11,426 |
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2026-01-05 | Option exercise | 25,136 | $1.55 | 38,961 |
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2026-01-05 | Option exercise | 64,265 | $1.55 | 99,611 |
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2025-11-14 | Option exercise | 87,100 | $1.55 | 135,005 |
|
Xeris Biopharma Holdings Inc XERS
Stock Option (Right to Buy) · derivative
|
2025-11-14 | Option exercise | 87,100 | $0.00 | |
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2025-11-13 | Option exercise | 8,970 | $1.55 | 13,904 |
|
Xeris Biopharma Holdings Inc XERS
Stock Option (Right to Buy) · derivative
|
2025-11-13 | Option exercise | 8,970 | $0.00 | |
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2025-11-13 | Sell | 23,242 | $7.46 | 173,385 |
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2025-08-01 | Tax withheld | 36,918 | $5.38 | 198,619 |
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2025-01-31 | Tax withheld | 110,750 | $3.56 | 394,270 |
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2025-01-31 | Tax withheld | 110,750 | $3.56 | 394,270 |
| showing 20 of 75 most recent transactions | |||||